News & Perspective

Nov 15, 2012

Nov 15, 2012

FDA panel endorses H5N1 vaccine with adjuvant

(CIDRAP News) – A government advisory committee yesterday endorsed the safety and immunogenicity of an adjuvant-containing H5N1 influenza vaccine proposed for inclusion in the US pandemic emergency stockpile, signaling that it could become the first adjuvanted flu vaccine to win approval in the United States.